Kit Preparation With a Short-Lived Generator Eluate
A nuclear pharmacy prepares a Tc-99m sulfur colloid kit for same-day lymphoscintigraphy. The eluate available was eluted 12 hours ago and has been sitting in the lead pig. The kit instructions specify that the eluate must be used within a certain time after elution and that the preparation must meet radiochemical purity (RCP) limits. The technologist prepares the kit, and the pharmacist performs a quality control check. The RCP result is 91%, while the kit's minimum specification is 92%. The patient is scheduled in 90 minutes. The pharmacist must decide whether to release the preparation.
1. Should the pharmacist release a preparation with 91% RCP against a 92% specification? What are the considerations?
Read the worked answer
No - the preparation should not be released as-is. The kit specification (92% minimum) is a release criterion; a result of 91% is a failure.
Considerations:
- RCP limits are product-specific and non-negotiable for release unless the facility's validated policy explicitly permits a documented deviation with clinical justification - and even then, only after assessing whether the lower RCP affects the diagnostic yield.
- For sulfur colloid used in lymphoscintigraphy, lower RCP means more free pertechnetate and/or hydrolyzed-reduced Tc, which can alter biodistribution and degrade the study.
- The eluate age is a plausible cause. A 12-hour-old eluate has lower Tc-99m activity and a higher proportion of long-lived impurities/radiocontaminants relative to fresh eluate; some kits specify a maximum eluate age. The pharmacist should check the kit's eluate-age requirement.
- Options: repeat the RCP assay to rule out technique error; if confirmed, discard and prepare a fresh kit with a fresher eluate if available, or reschedule.
Documentation should include the failed RCP, the disposition, and the corrective action.
2. A repeat RCP assay confirms 91%. The patient's surgery is scheduled and the study cannot be delayed. What alternatives should the pharmacist explore, and what is the reasoning?
Read the worked answer
With a confirmed 91% RCP and an immovable clinical schedule, the pharmacist should explore:
- Fresh eluate - if the generator can be eluted now (respecting the minimum interval since the last elution), prepare a new kit and reassay. Fresh eluate generally gives better RCP and is the cleanest fix.
- Alternative radiopharmaceutical - determine whether the clinical question can be answered with a different agent available on site (e.g., a filtered sulfur colloid preparation or another validated colloid product) that meets its own RCP specification.
- Escalate to the authorized user/referring clinician - explain that the preparation failed specification and that proceeding would mean administering a product outside its release criteria. The clinician decides whether to accept a documented deviation or to change the plan.
Reasoning: the pharmacist's role is to protect product quality and patient safety while helping the clinical team find a compliant path. Releasing a failed preparation without clinician awareness and documentation is not acceptable. If a deviation is accepted, it must be documented with the RCP result, the clinical rationale, and the clinician's concurrence.